Skip to main content

Find Clinical Trials

Home
Conditions
Neoadjuvant Immunochemotherapy

Clinical trial condition

Neoadjuvant Immunochemotherapy

Explore clinical trials studying Neoadjuvant Immunochemotherapy. Study availability and eligibility vary by location and protocol.

3 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Neoadjuvant Immunochemotherapy trial results

Recruiting

Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma

NCT07086469

Conditions: Carcinoma, Carcinoma, Squamous Cell, Chemoradiotherapy, +16 more
Locations: Sun yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy

NCT07088354

Conditions: Carcinoma, Carcinoma, Squamous Cell, Deep Learning, +15 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

Efficacy and Safety of a Third-Course of Neoadjuvant Immunochemotherapy Combined With SBRT in Locally Advanced Head and Neck Squamous Cell Carcinoma Patients With Stable Disease After Two Treatment Courses: A Single-Arm Exploratory Study

NCT06722495

Conditions: LA HNSCC, Neoadjuvant Immunochemotherapy, SBRT
Locations: Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University Guangzhou, Guangdong, China

View Trial Details